Jentadueto
Generic: linagliptin metformin
Manufacturer: Boehringer Ingelheim · Program: Boehringer Cares Patient Assistance Program
Apply for AssistanceEligibility Criteria
Insurance Requirement
Uninsured or underinsured US patients who meet eligibility
Residency
US resident
Eligibility requirements for US patients; specific thresholds not detailed in search results
Program Information
Processing Time
4–8 weeks
Delivery Method
shipped to patient
Application Method
Multiple
Reauthorization
Required — annual
Typically Required Documents
ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.
- proof of residency
- proof of income
- prescription
Indicated For
type 2 diabetes
About This Medication
# Boehringer Cares Patient Assistance Program Patient Guide: How to Get Jentadueto at Low or No Cost Jentadueto (linagliptin/metformin) is a prescription medication used to help manage **type 2 diabetes** in adults, combining two active ingredients to improve blood sugar control when diet and exercise alone are not enough. The **Boehringer Cares Patient Assistance Program** from Boehringer Ingelheim offers this medication at low or no cost to eligible uninsured or underinsured US patients who meet income and other requirements. ## About Jentadueto **Jentadueto** is an oral tablet that contains **linagliptin**, a DPP-4 inhibitor that helps the body release more insulin after meals, and **metformin**, a biguanide that reduces glucose production in the liver and improves insulin sensitivity. It's typically taken twice daily with meals to minimize stomach upset. Common side effects include nausea, diarrhea, and upper respiratory infections, but it does not cause low blood sugar (hypoglycemia) when used alone. Always consult your doctor for personalized advice, as it's not for type 1 diabetes or diabetic ketoacidosis.[1][3] This program helps patients access Jentadueto without high out-of-pocket costs, covering free medication for those who qualify. It's designed for long-term use with reauthorization needed periodically. ## Who Qualifies? Eligibility focuses on US residents who are **uninsured or underinsured** and meet financial criteria. The program targets patients unable to afford their medications despite other resources. Key requirements include: - US citizenship or legal residency. - No or limited prescription insurance coverage. - Income within program guidelines (specific Federal Poverty Level (FPL) thresholds not publicly detailed but typically around 400-500% FPL for similar programs; contact program for exacts). - Valid prescription from a US-licensed healthcare provider. **Proof of residency, income, and prescription** are required. Families of various sizes may qualify, but exact household income limits are not specified in available details—call the program or visit RxAssist for updates.[1] ## Income Eligibility Breakdown Specific income thresholds are not detailed in program listings, noting only that eligibility is for US patients meeting financial need. Below is a general table based on common patient assistance structures (e.g., up to 400-500% FPL); verify with Boehringer Ingelheim for precise 2026 figures, as they adjust annually. | Household Size | Estimated Max Annual Income (400% FPL) | Estimated Max Annual Income (500% FPL) | |---------------|---------------------------------------|---------------------------------------| | 1 (Individual) | $60,240 | $75,300 | | 2 (Couple) | $81,760 | $102,200 | | 3 | $103,280 | $129,100 | | 4 | $124,800 | $156,000 | *Notes: FPL-based; Alaska/Hawaii higher. Actual thresholds may vary—program states 'specific thresholds not detailed.' Income includes all household sources.[1] ## Insurance Requirements The program is for **uninsured or underinsured US patients**. If you have Medicare, Medicaid, or private insurance, you may still qualify if you face high copays or denials (underinsured). Those with comprehensive coverage typically do not qualify. Medicare Part D patients should exhaust other options first, like Extra Help. Provide proof of insurance status or denial letters.[1] ## Step-by-Step Application Process 1. **Get a Prescription**: Ask your doctor for a prescription specifying Jentadueto dosage and quantity. 2. **Gather Documents**: Collect proof of residency (e.g., utility bill), proof of income (e.g., tax returns, pay stubs for all household), prescription, and insurance details/denial if applicable. 3. **Choose Application Method**: Multiple options available—online, mail, fax, or phone (details via RxAssist or manufacturer).[1] 4. **Submit Application**: Send to Boehringer Ingelheim Cares. No specific phone/URL listed; search RxAssist.org or call 1-800-556-8317 (general BI line) for forms. 5. **Wait for Approval**: Processing time varies (typically 2-4 weeks). 6. **Receive Medication**: Shipped directly to your home if approved.[1] Applications can be submitted by patients, doctors, or advocates. ## Timeline and Delivery Expect **2-4 weeks** for processing after complete submission, though it may be faster. Medication is **shipped free to the patient's home**, usually a 3-month supply initially. **Reauthorization is required** annually or per guidelines—resubmit income/residency proof before supply ends to avoid gaps.[1] ## Alternatives if Denied - **Appeal**: Contact the program for reasons and resubmit missing info. - **Other Programs**: Check Partnership for Prescription Assistance (PPARx.org), NeedyMeds, or RxAssist for alternatives. - **Generic Options**: Linagliptin/metformin generics may be cheaper; discuss with doctor. - **Manufacturer Coupons**: BI offers savings cards for commercially insured (not via this program).[3] - **State Programs**: Medicaid, state pharmaceutical aid, or clinic samples. - **No biosimilars** available for Jentadueto.[1] ## Disclaimer This guide is for informational purposes only and based on available data as of 2025. Eligibility, processes, and income limits can change—always verify directly with Boehringer Ingelheim Cares Foundation or RxAssist.org. Not medical advice; consult your healthcare provider. Boehringer Ingelheim does not endorse third-party sites.[1][2]
Program information last verified: March 25, 2026
Ready to apply for Jentadueto assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.